Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection

BACKGROUND: Neoadjuvant chemotherapy (NC) is an established therapy in breast cancer, able to downstage positive axillary lymph nodes, but might hamper their detectibility. Even if clinical observations suggest lower lymph node yield (LNY) after NC, data are inconclusive and it is unclear whether NC...

Descripción completa

Detalles Bibliográficos
Autores principales: Erbes, Thalia, Orlowska-Volk, Marzenna, zur Hausen, Axel, Rücker, Gerta, Mayer, Sebastian, Voigt, Matthias, Farthmann, Juliane, Iborra, Severine, Hirschfeld, Marc, Meyer, Philipp T, Gitsch, Gerald, Stickeler, Elmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884010/
https://www.ncbi.nlm.nih.gov/pubmed/24386929
http://dx.doi.org/10.1186/1471-2407-14-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884010/
https://www.ncbi.nlm.nih.gov/pubmed/24386929
http://dx.doi.org/10.1186/1471-2407-14-4

Ejemplares similares